Stifel analyst Brian Chin raised the firm’s price target on Teradyne (TER) to $325 from $280 and keeps a Buy rating on the shares. Given Teradyne’s near-term upside guidance and momentum, the firm revised its calendar year 2026 and 2027 estimates and argues that a premium valuation is “warranted.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne downgraded to Market Perform from Outperform at Northland
- Teradyne price target raised to $335 from $275 at Susquehanna
- Teradyne price target raised to $305 from $195 at Baird
- Teradyne price target raised to $325 from $215 at Citi
- Teradyne price target raised to $300 from $230 at Goldman Sachs
